CONFOCALMICROSCOPY Archives

November 2002

CONFOCALMICROSCOPY@LISTS.UMN.EDU

Options: Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
"Benoist, Christophe" <[log in to unmask]>
Reply To:
Confocal Microscopy List <[log in to unmask]>
Date:
Mon, 25 Nov 2002 13:48:15 -0500
Content-Type:
text/plain
Parts/Attachments:
text/plain (9 lines)
Search the CONFOCAL archive at
http://listserv.acsu.buffalo.edu/cgi-bin/wa?S1=confocal

Joslin Diabetes Center / Harvard Medical School
Imaging Core operator/engineer
You will participate in a team effort researching the mechanism and pathogenesis of autoimmune Diabetes. We are setting up an experimental microscopy system  for high-throughput time lapse analysis of cell-cell interaction and activation, in the context of autoimmune diabetes. This is a multi-disciplinary project involving with biologists, image analysis programmers and clinicians. You will participate in the implementation of the instrument, operate it, advise researchers in the design of cell imaging experiments, and assist with the handling and analysis of data. Responsibilities will include the operation and basic maintenance, and continued development of the instrument in liaison with Joslin and supplier's staff. We are looking for someone with a keen interest in complex instrumentation and also a team player, as you will work in close collaboration with experts from diverse fields .
Experience with complex microscopy systems, or with opto-electronic systems of like complexity, is required (2+ years). A basic biology background is also needed, as well and facility with scientific software. Please contact [log in to unmask]
Located in the center of Boston's medical community, Joslin Diabetes Center is an international leader in diabetes and endocrine disease treatment, research, and education. Established in 1898, and affiliated with Harvard Medical School, Joslin leads the field in both basic and clinical research, and is devoted to educating both patients and professionals to this serious disease that currently affects more than 16 million Americans.

ATOM RSS1 RSS2